Neoadjuvant Therapy Schemes combined with adjuvant Therapy for Patients   with muscle invasive Bladder Cancer before or after radical Cystectomy A   randomized, open, multicenter, global Phase-III Study to Determine the   Efficacy and Safety of Durvalumab in combination with Gemcitabine plus   Cisplatin (G plus C) for neoadjuvant Treatment, followed by Durvalumab   alone for adjuvant Treatment in Patients with muscle invasive Bladder   Cancer ( NIAGARA) - AUO AB 74/20

Dokumenttyp:: Editorial Material
Autor(en):: Rexer, Heidrun; Kuebler, Hubert; Retz, Margitta
Titel:: Neoadjuvant Therapy Schemes combined with adjuvant Therapy for Patients with muscle invasive Bladder Cancer before or after radical Cystectomy A randomized, open, multicenter, global Phase-III Study to Determine the Efficacy and Safety of Durvalumab in combination with Gemcitabine plus Cisplatin (G plus C) for neoadjuvant Treatment, followed by Durvalumab alone for adjuvant Treatment in Patients with muscle invasive Bladder Cancer ( NIAGARA) - AUO AB 74/20
Zeitschriftentitel:: Aktuelle Urol
Jahr:: 2021
Band / Volume:: 52
Heft / Issue:: 03
Seitenangaben Beitrag:: 220-221
Volltext / DOI:: doi:10.1055/a-1398-9963
PubMed:: http://view.ncbi.nlm.nih.gov/pubmed/34020502
Print-ISSN:: 0001-7868
TUM Einrichtung:: Urologische Klinik und Poliklinik
BibTeX

Vorkommen: